about
Standardization of cytokine flow cytometry assaysDoes HIV Exploit the Inflammatory Milieu of the Male Genital Tract for Successful Infection?A subset of circulating blood mycobacteria-specific CD4 T cells can predict the time to Mycobacterium tuberculosis sputum culture conversionEffect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosisEnrolling adolescents in research on HIV and other sensitive issues: lessons from South AfricaPeptide impurities in commercial synthetic peptides and their implications for vaccine trial assessmentTransmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage.Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study.Adaptive changes in HIV-1 subtype C proteins during early infection are driven by changes in HLA-associated immune pressure.A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis.FOXP3 expression is upregulated in CD4T cells in progressive HIV-1 infection and is a marker of disease severity.Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infectionAIDS-related mycoses: the way forward.Intra- and inter-clade cross-reactivity by HIV-1 Gag specific T-cells reveals exclusive and commonly targeted regions: implications for current vaccine trialsThe Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells.SPORE series winner. Immunology for clinicians: a "Trojan Horse" approach.Fluidity of HIV-1-specific T-cell responses during acute and early subtype C HIV-1 infection and associations with early disease progression.A dead-end host: is there a way out? A position piece on the ebola virus outbreak by the international union of immunology societies.Rapid disease progression in HIV-1 subtype C-infected South African women.Delaying BCG vaccination until 8 weeks of age results in robust BCG-specific T-cell responses in HIV-exposed infants.Is obesity a risk factor for vaccine non-responsiveness?Virological and immunological factors associated with HIV-1 differential disease progression in HLA-B 58:01-positive individualsIn-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infantsDistinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infectionPassively transmitted gp41 antibodies in babies born from HIV-1 subtype C-seropositive women: correlation between fine specificity and protection.Killer-cell Immunoglobulin-like Receptor (KIR) gene profiles modify HIV disease course, not HIV acquisition in South African women.Delayed BCG vaccination results in minimal alterations in T cell immunogenicity of acellular pertussis and tetanus immunizations in HIV-exposed infantsThe PTAP sequence duplication in HIV-1 subtype C Gag p6 in drug-naive subjects of India and South Africa.Increased memory differentiation is associated with decreased polyfunctionality for HIV but not for cytomegalovirus-specific CD8+ T cellsA high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infectionTemporal association of HLA-B*81:01- and HLA-B*39:10-mediated HIV-1 p24 sequence evolution with disease progression.Intersubtype differences in the effect of a rare p24 gag mutation on HIV-1 replicative fitness.Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.Impact of mucosal inflammation on cervical human immunodeficiency virus (HIV-1)-specific CD8 T-cell responses in the female genital tract during chronic HIV infectionPlasma interferon-gamma-inducible protein 10 can be used to predict viral load in HIV-1-infected individuals.Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load.Human immunodeficiency virus-specific gamma interferon enzyme-linked immunospot assay responses targeting specific regions of the proteome during primary subtype C infection are poor predictors of the course of viremia and set pointRapid, complex adaptation of transmitted HIV-1 full-length genomes in subtype C-infected individuals with differing disease progressionHeterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function.
P50
Q24811983-44725FB3-A279-4798-80AC-2F530D809E3CQ26742167-3AEE493F-315E-425B-AD0C-D9E5CA5D4C0FQ28541001-A732F730-5C62-4EF2-B489-D6232CEC33ECQ28729980-D185D8EB-A433-4C89-B478-B098387F8A97Q33239623-6C4532FA-AB92-4233-8FFD-807EBC21A001Q33310152-909A308B-03AA-42ED-8EC5-34AF0309FB79Q33325923-D8A18EB5-2CEA-4CC2-BF68-2458CB1C16CAQ33328477-9D597268-78DC-40E8-B842-307D4708C521Q33606936-19666BBE-9FA0-49EC-8BDF-C8FF73CFBCEBQ33626683-9AE52DDF-8881-4BDF-8131-595064DFA242Q33644550-EA35D0D2-DA5F-4C5C-A9A5-E68228BD21D0Q33828583-A8E906E9-B91B-49B0-844E-1B9DFF895DECQ34030928-5820C636-ADC1-4FD2-BD2A-38FB63786973Q34055991-577018FB-2B45-4A0E-8AE2-A6C847653079Q34067001-F7D2D88A-2B46-4FE4-97CD-A2A4EE38BA92Q34142295-D12689F7-01B8-4006-A4EE-23486DBA4F73Q34295981-ECB0C7F4-A30C-4658-B3BD-96961F1E41C5Q34424660-CBA3A17C-AB02-4928-B0C8-92EDF27B7E31Q34736181-14DDC043-89D5-4DD5-9148-7D8125C7A081Q35055158-78CEAD92-75C1-478D-AC27-9D4964F0EDC8Q35070512-B502401E-D979-4B69-8343-669EA87D93F7Q35077768-4C35A0DE-D2A4-4D33-A94B-4530736DFE69Q35097422-09943F3F-0089-4BA3-8968-9DD2243C0EF5Q35784244-18865650-82F0-46EF-B748-6A77B423AC42Q35867981-E3E8C924-F7F7-43D2-AB36-36BA023840ACQ35904239-31616665-2FCF-4503-A5BC-D2E02153223AQ36037618-292CBA5E-50CF-4D4D-8302-7949B5FC0762Q36259014-AE3A47FE-1EE7-4120-80FC-719AF2FC63BCQ36303623-682AF16E-C311-41F1-8747-6FC3C04D397CQ36315080-1B06C3E8-32FA-4526-AF8D-8EB2D4F30E19Q36363854-DC4C66E3-F7BE-4813-BE1B-0CD6EFA9226AQ36414578-D2493A45-6148-4416-9A5F-B57D40937FCBQ36497283-CB88B8A4-AEE3-4258-A5B9-F89798D26C08Q36600351-ECA5E3B7-CCE3-4606-866C-0D08698DFD61Q36845972-ACF3FCC2-04D8-4D23-9D92-F7423502327FQ36929674-264AFDBC-2357-4BE8-88F3-D3FBA4B4A24EQ37009811-96B81946-EEA7-44EF-909A-D38F1E469F11Q37033201-269BB72D-BF7B-4F70-A651-A4ED1532BE0CQ37039116-00296378-E792-43E5-928E-6529D8DD66B0Q37275906-9B5E17D1-AD2C-411D-92E0-34EE0A6B2A3A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Clive M. Gray
@ast
Clive M. Gray
@en
Clive M. Gray
@es
Clive M. Gray
@nl
Clive M. Gray
@sl
type
label
Clive M. Gray
@ast
Clive M. Gray
@en
Clive M. Gray
@es
Clive M. Gray
@nl
Clive M. Gray
@sl
altLabel
Clive Gray
@en
prefLabel
Clive M. Gray
@ast
Clive M. Gray
@en
Clive M. Gray
@es
Clive M. Gray
@nl
Clive M. Gray
@sl
P106
P1153
7402204152
P21
P31
P496
0000-0002-9293-901X